Tag: Advanced Pharmaceutical Research Award

Shivani Chib | Pharmaceutical Science | Young Scientist Award

Published on by World Science Awards

Young Scientist Award

Shivani Chib — Central University of Punjab

Shivani Chib
Affiliation Central University of Punjab
Country India
Scopus ID 57946271800
Documents 24
Citations 315
h-index 10
Subject Area Pharmaceutical Science
Event World Science Awards
Google Scholar ID 8hFOqyEAAAAJ

Shivani Chib is a researcher affiliated with the Central University of Punjab, India, whose stated subject area is Pharmaceutical Science. Available bibliographic information identifies 24 documents, 315 citations, and an h-index of 10 in the supplied Scopus profile. These indicators provide a quantitative overview of the research record represented in the cited author profile. [1]

This academic recognition page presents the research profile in the context of the Young Scientist Award associated with the World Science Awards. The article is intended as a structured scholarly summary and distinguishes bibliographic indicators from broader qualitative considerations of research contribution and relevance. [3]

Abstract

Shivani Chib is associated with the Central University of Punjab and works within the broad field of Pharmaceutical Science. The supplied bibliometric record reports 24 documents, 315 citations, and an h-index of 10. [1] These measures can be used to describe the documented visibility and citation history of the research output represented by the identified Scopus author profile. The researcher is considered in relation to the Young Scientist Award under the World Science Awards, with the available information supporting an assessment based on research activity, scholarly output, and bibliometric indicators. [3]

Keywords

  • Young Scientist Award
  • Shivani Chib
  • Pharmaceutical Science
  • Pharmaceutical Research
  • Bibliometrics
  • Research Impact
  • Central University of Punjab
  • World Science Awards

Introduction

Pharmaceutical Science encompasses interdisciplinary research concerned with the discovery, development, formulation, evaluation, and application of pharmaceutical products and related technologies. Researchers working in this field contribute to the scientific evidence base that supports advances in medicines, drug delivery, pharmaceutical analysis, and associated areas of biomedical research.

Within this broader academic context, Shivani Chib is identified with the Central University of Punjab in India. The supplied research record indicates a body of 24 documents and a citation count of 315, alongside an h-index of 10. [1] Such indicators are useful for describing publication and citation activity, although they do not independently establish the quality, originality, or practical significance of individual research contributions.

Research Profile

The available profile information places Shivani Chib within Pharmaceutical Science and identifies the Central University of Punjab as the institutional affiliation. The Scopus author identifier supplied for the researcher is 57946271800. [1] The corresponding Google Scholar identifier is 8hFOqyEAAAAJ, providing an additional route for locating scholarly material associated with the researcher. [2]

Bibliometric indicators should be interpreted in relation to publication age, disciplinary citation practices, authorship patterns, journal characteristics, and the nature of the research questions addressed. Consequently, the reported values are best treated as descriptive indicators rather than as a complete evaluation of scientific merit.

Research Contributions

The supplied information identifies Pharmaceutical Science as Shivani Chib’s principal subject area. On the basis of the available bibliographic record, the research profile can be considered within the wider pharmaceutical research ecosystem, where scholarly contributions may involve experimental investigation, pharmaceutical development, analytical approaches, formulation research, or related interdisciplinary work. Specific research contributions should be assessed from individual publications and their associated abstracts, methods, results, and citation contexts rather than inferred solely from aggregate metrics.

These elements provide a concise quantitative and institutional description of the research profile. A complete scholarly evaluation would additionally consider the originality of individual studies, methodological rigor, reproducibility, collaboration, research relevance, and contributions to scientific knowledge.

Publications

The supplied Scopus information reports 24 documents associated with Shivani Chib’s author profile. [1] Because individual publication titles, journal names, publication years, article types, and DOI identifiers were not provided in the source information supplied for this article, this section does not assign specific publications or DOI records to the researcher without verification.

The complete publication record can be consulted through the researcher’s Scopus author profile and Google Scholar profile. These databases can provide publication-level information, citation records, author associations, and other bibliographic details. [1] [2]

Research Impact

The supplied bibliometric record reports 315 citations across 24 documents, producing an average of approximately 13.1 citations per document when calculated from the provided values. The reported h-index of 10 indicates that, within the cited record, at least ten publications have each received at least ten citations under the applicable indexing and counting conditions. [1]

Citation indicators can help describe scholarly visibility but should not be treated as standalone measures of research quality or societal impact. Citation patterns vary substantially among disciplines and publication types. A broader assessment of impact may include scientific influence, methodological contributions, collaboration, translation into practice, educational value, and relevance to pharmaceutical research.

Award Suitability

The Young Scientist Award associated with the World Science Awards provides a recognition framework in which research activity, scholarly contributions, academic development, and evidence of research influence may be considered. [3] Based on the supplied information, Shivani Chib has a documented research profile in Pharmaceutical Science, an institutional affiliation with the Central University of Punjab, 24 reported documents, 315 citations, and an h-index of 10. [1]

These characteristics provide a reasonable bibliometric basis for consideration within an early-career or young-scientist recognition context. Final award suitability, however, should be determined using the official award criteria and a complete evaluation of the researcher’s publications, originality, scientific contribution, academic trajectory, and supporting documentation rather than bibliometric indicators alone. [3]

  1. Verified bibliographic and citation information should be considered from the relevant scholarly databases.
  2. Individual publications should be reviewed for originality, methodological quality, and contribution to Pharmaceutical Science.
  3. The official World Science Awards criteria should be used for the final award assessment.

Conclusion

Shivani Chib is a Pharmaceutical Science researcher affiliated with the Central University of Punjab, India. The supplied Scopus record identifies 24 documents, 315 citations, and an h-index of 10, providing a measurable overview of the research activity represented by the profile. [1] The available information supports consideration of the researcher in connection with the Young Scientist Award, while a comprehensive award decision should incorporate publication-level evidence and the official evaluation criteria of the World Science Awards. [3]

References

    1. Elsevier. (n.d.). Scopus author details: Shivani Chib, Author ID 57946271800. Scopus.
      https://www.scopus.com/pages/authors/57946271800

Yi-Ping Huang | Pharmaceutical Science | Women Researcher Award

Published on by World Science Awards

Assoc. Prof. Dr. Yi-Ping Huang | Pharmaceutical Science | Women Researcher Award

Associate Professor from Department of Physiology, China Medical University, Taiwan

Yi-Ping Huang is an accomplished Associate Professor in the Department of Physiology at China Medical University, with over 32 years of experience in both teaching and research. His primary focus is on cancer treatment, specifically investigating the therapeutic effects of natural and synthetic compounds on cancer cells. Over the years, Huang has significantly contributed to the field, publishing numerous peer-reviewed articles and advancing the understanding of cancer treatment mechanisms, particularly apoptosis, DNA damage, and anti-metastasis pathways. His expertise extends to drug synergy, especially in combination with chemotherapy. He has also been involved in teaching innovations in physiology, emphasizing student engagement and educational research. Huang’s extensive research output and leadership in the field have made him a well-respected figure in the scientific community, as reflected in his numerous research projects and academic publications.

Professional Profile

Education

Yi-Ping Huang completed his undergraduate studies in Physiology at Yang-Ming University, laying the foundation for his extensive career in research and academia. His academic journey provided a strong base for his research into cancer treatment and physiological mechanisms. This solid educational background enabled Huang to develop expertise in a range of specialized topics, particularly in the therapeutic effects of natural compounds. Over the years, his continuous learning and commitment to his field have propelled his success, making him an established academic in the study of cancer therapy and physiology.

Professional Experience

Yi-Ping Huang has a long and distinguished career in both academia and research. As an Associate Professor at China Medical University, he has been instrumental in educating students and conducting cutting-edge research on cancer therapy. With over three decades of experience, Huang has led numerous research projects focusing on natural and synthetic compounds in cancer treatment. His role also includes teaching and mentoring students, guiding them in the latest scientific advancements. Huang’s professional experience is marked by extensive publications in high-impact journals, further showcasing his contributions to the scientific community and his leadership in advancing cancer research.

Research Interests

Yi-Ping Huang’s primary research interests revolve around the use of natural and synthetic compounds in cancer therapy. His work explores the mechanisms through which these compounds induce apoptosis, DNA damage, and inhibit metastasis in cancer cells. Huang is particularly focused on understanding how these compounds can synergize with chemotherapy drugs to overcome resistance and improve treatment outcomes. His ongoing research also investigates the therapeutic effects of compounds such as Demethoxycurcumin (DMC), Phenethyl Isothiocyanate (PEITC), and PW06 in various cancer types, including glioblastoma and colon cancer. These areas of interest align with his goal of advancing cancer therapy through the identification and development of novel therapeutic agents.

Research Skills

Yi-Ping Huang’s research skills are extensive and diverse, ranging from molecular biology techniques to cancer therapy research. He possesses a deep understanding of cancer cell biology, particularly in apoptosis, DNA repair, and metastasis inhibition. Huang has demonstrated proficiency in the use of various experimental models to study the effects of natural and synthetic compounds on cancer cells, including in vitro and in vivo models. His expertise extends to studying drug interactions and mechanisms of drug resistance, especially in relation to chemotherapy. Huang’s interdisciplinary approach to research, combining pharmacology, molecular biology, and cancer therapy, has led to groundbreaking studies that have contributed significantly to the field.

Awards and Honors

Throughout his illustrious career, Yi-Ping Huang has received numerous awards and honors that recognize his contributions to the scientific community. His groundbreaking research in cancer therapy, particularly in the use of natural and synthetic compounds, has earned him accolades from academic institutions and scientific organizations. Huang’s work on compounds such as Demethoxycurcumin and Phenethyl Isothiocyanate has been widely recognized in the field of oncology research. His consistent contributions to cancer treatment research and his leadership in academia have earned him recognition as a leading expert in his field, enhancing his reputation as an influential figure in cancer research.

Conclusion

Yi-Ping Huang’s career has been defined by significant contributions to cancer research, particularly in the development and understanding of natural and synthetic compounds as therapeutic agents. His research focuses on the molecular mechanisms of apoptosis, DNA damage, and anti-metastasis, offering potential for groundbreaking advancements in cancer treatment. With over three decades of experience, Huang’s work continues to influence both basic and clinical cancer research. His leadership in academia, coupled with his innovative research, positions him as a respected figure in the scientific community. As he continues to push the boundaries of cancer therapy, his contributions are likely to have a lasting impact on the field.

Publication Top Notes

M084 causes cell cycle arrest and inhibits voltage-gated Na⁺ and K⁺ channels in neuronal N2A cells
Authors: Iat Lon Leong, Chinmin Chuang, Chenghsun Wu, Yukman Leung, Yiping Huang
Year: 2025

2. MCU-i4, a mitochondrial Ca²⁺ uniporter modulator, induces breast cancer BT474 cell death by enhancing glycolysis, ATP production and reactive oxygen species (ROS) burst
Authors: Edmund Cheung So, Louis Wing Cheong Chow, Chinmin Chuang, Yukman Leung, Yiping Huang
Year: 2025

3. Physalin A induces apoptosis through conjugating with Fas-FADD cell death receptor in human oral squamous carcinoma cells and suppresses HSC-3 cell xenograft tumors in NOD/SCID mice
Authors: Fu Shin Chueh, Shengyao Hsu, Kuangchi Lai, Yiping Huang, Wen Tsong Hsieh
Year: 2025

4. PEITC Induces DNA Damage and Inhibits DNA Repair-Associated Proteins in Human Retinoblastoma Cells In Vitro
Authors: Shengyao Hsu, Yiping Huang, Techun Hsia, Fu Shin Chueh, Chaolin Kuo
Year: 2024

5. Armillaria mellea Mycelia Alleviate PM2.5-Induced Pulmonary Inflammation in Murine Models
Authors: Yiping Huang, Yutsen Huang, Huiyu Wu, Chinchu Chen, Chih Ho Lai
Year: 2024

6. RAGE participates in the intracellular transport of Campylobacter jejuni cytolethal distending toxin
Authors: Yufang Chang, Yiping Huang, Chiahuei Chou, Chenghsun Chiu, Chih Ho Lai
Year: 2024
Citations: 2

7. PW06 suppresses cancer cell metastasis in human pancreatic carcinoma MIA PaCa-2 cells via the inhibitions of p-Akt/mTOR/NF-κB and MMP2/MMP9 signaling pathways in vitro
Authors: Yiping Huang, Chunan Yeh, Yishih Ma, Jin Cherng Lien, Wen Tsong Hsieh
Year: 2024
Citations: 2

Bashige Chiribagula Valentin | Pharmaceutical Science | Best Researcher Award

Published on by World Science Awards

Prof. Bashige Chiribagula Valentin | Pharmaceutical Science | Best Researcher Award

Professor of UNILU, Congo.

Dr. Bashige Chiribagula Valentin is a prominent academic and researcher specializing in ethnopharmacology, medicinal chemistry, and quality control. Currently a professor at the University of Lubumbashi, he has held roles including department head, research specialist in pharmacognosy, and educator in pharmacology. His research focuses on the ethnobotanical, phytochemical, and pharmacological properties of medicinal plants, with significant contributions to the development of traditional medicine-based therapies, such as antimalarial and antimicrobial agents. Dr. Chiribagula has led various projects aimed at enhancing the quality and efficacy of herbal remedies and has published extensively in reputed journals. His work includes studies on plant-based treatments for malaria, diabetes, and wound healing, reflecting his commitment to integrating traditional knowledge with modern scientific approaches. His leadership in the academic and scientific community, coupled with his impactful research, underscores his candidacy for the Best Researcher Award.

Profile
Education

Dr. Bashige Chiribagula Valentin’s educational background is extensive and well-rounded. He earned his Doctorate in Pharmaceutical Sciences from the University of Lubumbashi (UNILU) and the Université de Mons (UMONS) in 2021, specializing in Pharmacognosy with a focus on ethnopharmacology. Prior to this, he obtained a Diplôme d’Études Approfondies in Pharmacognosy from UNILU in 2016. His foundational education includes a Diplôme de Pharmacie d’Industrie et Analyse de Médicaments from UNILU, completed in 2012, and a Diplôme d’Études Générales en Sciences Pharmaceutiques from the University of Kinshasa (UNIKIN) in 2006. His academic journey demonstrates a strong commitment to advancing knowledge in pharmaceutical sciences, particularly in the areas of pharmacognosy and ethnopharmacology.

Professional Experience

Dr. Bashige Chiribagula Valentin has an extensive and diverse professional background in the field of pharmacognosy and ethnopharmacology. He has served as a Professor at the University of Lubumbashi since 2022, where he also holds positions as President of juries and Secretary of the Department of Pharmacology. His career at the university began as an Assistant in 2013, progressing to a Chief of Works and Specialist in Pharmacognosy. In addition to his academic roles, Dr. Chiribagula has been actively involved in the pharmaceutical industry as a Quality Control Manager at PROMED Lubumbashi. His research focuses on ethnopharmacology, medicinal chemistry, and quality control of medicinal plants, contributing significantly to the development of traditional medicine projects. Dr. Chiribagula’s career also includes roles in secondary education and civil society, showcasing his dedication to both education and community service.

Research Interest

Dr. Bashige Chiribagula Valentin’s research focuses on the ethnopharmacological and medicinal properties of plants, particularly in the context of traditional medicine. His work spans the study of plant-based remedies for various diseases, including malaria and diabetes, with a strong emphasis on the pharmacognosy of medicinal plants. Dr. Chiribagula’s research integrates ethnobotanical surveys, phytochemical analysis, and pharmacological testing to explore and validate the therapeutic potential of natural substances. His projects include the development of medicinal plants for wound healing, anti-malarial, anti-ulcer, and antibacterial applications. Additionally, he investigates the nutritional and medicinal benefits of indigenous fungi, fruits, and vegetables. His research aims to bridge traditional knowledge with modern scientific validation, contributing to the development of effective, natural therapeutic agents and enhancing the quality of life in the Democratic Republic of Congo.

Research Skills

Dr. Bashige Chiribagula Valentin demonstrates a robust set of research skills essential for advancing his field of study. His expertise spans ethnopharmacology, medicinal chemistry, and quality control, with a strong emphasis on the pharmacognostic and phytochemical evaluation of medicinal plants. Dr. Chiribagula excels in employing various analytical techniques, including chromatography (TLC, Flash, HPLC), spectral analysis (MS), and microbiological assays (antimicrobial testing, antioxidant assays). His proficiency in using statistical software such as SPSS and GraphPad supports his rigorous data analysis. Additionally, he has a solid background in experimental design and execution, demonstrated by his work on traditional medicine and natural product research. His ability to integrate traditional knowledge with scientific methodologies underscores his contributions to the development of novel therapeutic agents and quality control measures in pharmaceuticals. Dr. Chiribagula’s comprehensive approach and methodological skills are integral to his research successes.

Awards and Recognition

Dr. Bashige Chiribagula Valentin has garnered significant recognition for his contributions to pharmacognosy and ethnopharmacology. He was honored as the “Major de Promotion” in 2012 and achieved notable accolades in 2019, securing first place at the MT180 regional AUF competition and second place at the national MT180 competition. His scholarly excellence is highlighted by his award-winning research on ethnobotanical studies and medicinal plants, which has been recognized in several prestigious journals. Dr. Chiribagula’s impactful work in the development of medicinal plant-based treatments, including those for malaria and wound healing, has further solidified his reputation in the scientific community. These awards underscore his dedication to advancing knowledge in pharmaceutical sciences and his commitment to improving public health through innovative research.

Conclusion

Bashige Chiribagula Valentin is a strong candidate for the Research for Best Researcher Award due to his substantial contributions to ethnopharmacology, his significant publications, and his active role in academia and the pharmaceutical industry. His expertise in traditional medicine and his impactful research on medicinal plants, coupled with his notable awards and professional experience, underline his qualifications for the award.

Publications Top Notes

  • Ethnomedical Knowledge of Plants Used in Nonconventional Medicine for Wound Healing in Lubumbashi, Haut‐Katanga Province, DR Congo
    • Authors: Bashige Chiribagula Valentin
    • Year: 2024
  • Ethnomedicinal Knowledge of Plants Used in Nonconventional Medicine in the Management of Diabetes Mellitus in Kinshasa (Democratic Republic of the Congo)
    • Authors: Bashige Chiribagula Valentin
    • Year: 2023
  • Ethnobotanical study of plants used by traditional healers in Lubumbashi (Democratic Republic of Congo) in the management of typhoid fever
    • Authors: Bashige Chiribagula Valentin
    • Year: 2022
  • Activité antioxydante de 53 plantes réputées antimalariques en République Démocratique du Congo
    • Authors: Bashige Chiribagula Valentin
    • Year: 2021
  • In vitro antioxidant activity and in vivo aphrodisiac activity in male Cavia porcellus of Albizia adianthifolia (Schum.) W. Wight and Pericopsis angolensis (Baker) Meeuwen
    • Authors: Bashige Chiribagula Valentin
    • Year: 2021
  • Knowledge, attitudes and practices among the population, towards COVID-19 in the Lubumbashi city (DR Congo): An online cross-sectional survey
    • Authors: Bashige Chiribagula Valentin
    • Year: 2021
  • Mineral elements analysis and total flavonoids content in the fresh leaves from two varieties of Hibiscus sabdariffa L. consumed as vegetable in Lubumbashi (DR Congo)
    • Authors: Bashige Chiribagula Valentin
    • Year: 2021
  • Antimicrobial, antioxidant activities and toxicity on Cavia porcellus of Dialium angolense Welw. Ex Oliv, a traditional medicinal plant from Bagira in Eastern of DR Congo
    • Authors: Bashige Chiribagula Valentin
    • Year: 2020
  • Ethnobotanical study of medicinal plants used in the treatment of sexual dysfunctions in traditional medicine in Kampemba-Lubumbashi, DR Congo
    • Authors: Bashige Chiribagula Valentin
    • Year: 2020
  • Antiplasmodial, antioxidant and toxicological study of leaves extracts of Dalbergia katangensis Lecheneaud (Fabaceae) from Eastern DR Congo
    • Authors: Bashige Chiribagula Valentin
    • Year: 2020